Fluorometric Assay of Verapamil in Biological Fluids and Tissues

scientific article published on March 1, 1976

Fluorometric Assay of Verapamil in Biological Fluids and Tissues is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JPS.2600650330
P953full work available at URLhttps://api.elsevier.com/content/article/PII:S0022354915406586?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0022354915406586?httpAccept=text/plain
P698PubMed publication ID1263097

P2093author name stringR. G. McAllister
S. M. Howell
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectverapamilQ410291
pharmaceutical scienceQ7180763
P304page(s)431-432
P577publication date1976-03-01
P1433published inJournal of Pharmaceutical SciencesQ3186933
P1476titleFluorometric assay of verapamil in biological fluids and tissues
Fluorometric Assay of Verapamil in Biological Fluids and Tissues
P478volume65

Reverse relations

cites work (P2860)
Q79745004A common method for the determination of several calcium channel blockers using an HPLC system with ultraviolet detection
Q72925190Absence of slow channel-dependent conduction within the His-Purkinje (bundle branch) reentrant circuit: A clinical and experimental study of the effects of verapamil
Q71242375Analysis of verapamil in plasma by liquid chromatography
Q41741431Antiarrhythmic actions of verapamil against ischaemic arrhythmias in the rat
Q39373749Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine
Q40146301Calcium Antagonists Pharmacokinetic Properties
Q40146304Calcium antagonists. Clinical use in the treatment of arrhythmias
Q40167931Clinical Pharmacokinetics of Verapamil
Q70478662Clinical pharmacokinetics of verapamil in patients with atrial fibrillation
Q41606809Decreased uptake of 5-hydroxytryptamine and dopamine into blood platelets from depressed patients [proceedings]
Q44199634Determination of verapamil by adsorptive stripping voltammetry in urine and pharmaceutical formulations
Q43781109Determination of verapamil in pharmaceutical formulations using atomic emission spectrometry
Q35885320Effect of verapamil on blood pressure and lesions in heart and kidney of rats made hypertensive by deoxycorticosterone (DOC).
Q33821933Effects of verapamil on ventricular tachycardias possibly caused by reentry, automaticity, and triggered activity
Q72671407Electropharmacology of the Slow-Channel Inhihitors in the Management of Cardiac Arrhythmias: Verapamil
Q41507555GLC Assay of Verapamil in Plasma: Identification of Fluorescent Metabolites after Oral Drug Administration
Q70879017High-performance liquid chromatographic determination of verapamil in plasma by fluorescence detection
Q39529940Kinetic Spectrofluorometric Determination of Certain Calcium Channel Blockers via Oxidation with Cerium (IV) in Pharmaceutical Preparations
Q58130404Quantitation of Verapamil and Norverapamil in Small Blood Samples From the Rat by High Performance Liquid Chromatography
Q58268840Rapid Quantitation of Verapamil in Plasma by High-Performance Liquid Chromatography
Q71044450Rapid high-performance liquid chromatographic method for the measurement of verapamil and norverapamil in blood plasma or serum
Q67003135Rapid high-pressure liquid chromatographic analysis of verapamil in blood and plasma
Q74455151Simplified reversed-phase HPLC method with spectrophotometric detection for the assay of verapamil in rat plasma
Q52435676Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil.
Q58180268Spectrophotometric Assay of Certain Cardiovascular Drugs Through Charge Transfer Reactions
Q42532002The effects on left ventricular performance of nifedipine and verapamil in exercise-induced angina pectoris
Q40253273Verapamil hydrochloride: pharmacological properties and role in cardiovascular therapeutics
Q39720756Verapamil: a review of its pharmacological properties and therapeutic use.

Search more.